DINAMIQS

DINAMIQS is a contract development and manufacturing organisation (CDMO) for viral vectors used in cell and gene therapies, in particular adeno-associated viruses (AAV) and lentiviruses. It is based in the Bio-Technopark in Schlieren near Zurich.

The company offers vector production, process development, analytical services and fill-finish, as well as off-the-shelf vectors. In 2023 the Swiss company Siegfried acquired a majority stake, and DINAMIQS now operates as part of the Siegfried group.

In September 2025 it opened a cGMP manufacturing facility for viral vectors in Schlieren. In April 2026 it received a Swissmedic licence for the manufacturing and testing of viral vectors.